SR ONE CAPITAL MANAGEMENT, LLC bought ODTX

May 11, 2026 · Form 4 insider transaction

SR ONE CAPITAL MANAGEMENT, LLC bought 200,000 shares of Odyssey Therapeutics, Inc. at $18.00 per share, a transaction worth $3.60M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
200,000
Price
$18.00
Total value
$3.60M
Role10% owner
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 11, 2026
Filing dateMay 11, 2026
Shares owned after1,014,851
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The reported securities are held directly by AMZL, LP ("AMZL"). SR One Capital SMA Partners, LP ("SR One SMA Partners") is the general partner of AMZL, and SR One Capital Management is the general partner of SR One SMA Partners. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One SMA Partners, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.

View the original Form 4 on SEC EDGAR